Recombinant Canine IFN-gamma Protein

• Supplier: R&D Systems
• Catalog: 781-CG
• Category: Protein
• Prices: $289.00
• Sizes: 50 µg
• Species Reactivities: Dog
• Nature: Recombinant
• Source: E. coli -derived Gln24-Lys166, with an N-terminal Met
• Purity: >95%, by SDS-PAGE under reducing conditions and visualized by silver stain
• Bioactivity: Measured by its anti-viral activity on A‑72 canine fibroma cells infected with vesicular stomatitis virus (VSV). The ED 50 for this effect is 0.3-1.5 ng/mL.
• Endotoxin: <0.01 EU per 1 μg of the protein by the LAL method.
• SwissProt/Accession: P42161
• Gene: IFNG
• Sequence: Met

Product References

Recombinant Forms of Leishmania amazonensis Excreted/Secreted Promastigote - Recombinant Forms of Leishmania amazonensis Excreted/Secreted Promastigote

Petitdidier E, Pagniez J, Papierok G, Vincendeau P, Lemesre JL, Bras-Goncalves R. PLoS Negl Trop Dis. 2016 May 25;10(5):e0004614. doi:

Suppression of Canine Dendritic Cell Activation/Maturation and Inflammatory - Suppression of Canine Dendritic Cell Activation/Maturation and Inflammatory

Wheat WH, Chow L, Kurihara JN, Regan DP, Coy JW, Webb TL, Dow SW. Stem Cells Dev. 2017 Feb 15;26(4):249-262.

Long-lasting protection against canine visceral leishmaniasis using the - Long-lasting protection against canine visceral leishmaniasis using the

Lemesre JL, Holzmuller P, Goncalves RB, Bourdoiseau G, Hugnet C, Cavaleyra M, Papierok G. Vaccine. 2007 May 22;25(21):4223-34. Epub 2007 Mar 15.

Vaccination with irradiated Ancylostoma caninum third stage larvae induces a Th2 - Vaccination with irradiated Ancylostoma caninum third stage larvae induces a Th2

Fujiwara RT, Loukas A, Mendez S, Williamson AL, Bueno LL, Wang Y, Samuel A, Zhan B, Bottazzi ME, Hotez PJ, Bethony JM. Vaccine. 2006 Jan 23;24(4):501-9. Epub 2005 Aug 15.

Protection against experimental visceral leishmaniasis infection in dogs - Protection against experimental visceral leishmaniasis infection in dogs

Lemesre JL, Holzmuller P, Cavaleyra M, Goncalves RB, Hottin G, Papierok G. Vaccine. 2005 Apr 22;23(22):2825-40.